期刊文献+

全酿酒酵母HPV16-E7疫苗的构建及免疫原性研究 被引量:3

Construction of the whole yeast HPV16-E7 vaccine and study on its immunogenicity
下载PDF
导出
摘要 目的构建人乳头状瘤病毒16型(HPV16)E7重组全酿酒酵母疫苗,评价疫苗的免疫效应。方法将HPV16 E7 cDNA亚克隆入酵母表达载体pYES2/NT,重组质粒转化酿酒酵母,经诱导表达、热灭活制备全酵母HPV16-E7疫苗,免疫C57BL/6小鼠。ELISA、MTT、LDH法分别检测疫苗诱导的细胞因子、脾淋巴细胞增殖和细胞毒性T淋巴细胞(CTL)应答水平。结果全酵母疫苗能够有效表达HPV16-E7蛋白;疫苗小鼠免疫,能够刺激脾淋巴细胞增殖,并诱导出Th1型细胞因子和特异性CTL杀伤效应;免疫效果优于单纯HPV16-E7蛋白免疫(P<0.01)。结论全酵母疫苗既能表达HPV16-E7蛋白,又能有效诱导特异性CTL免疫应答。研究结果为进一步进行疫苗抗肿瘤疗效研究,提供了实验基础。 Objective To construct a whole recombinant yeast vaccine containing human papillomovirus type 16 (HPV16) E7 gene, and study on the immune response induced by the HPV16 - E7 vaccine. Methods The HPV16 E7 coding cDNA was subcloned into yeast expression vector and positive transformant stains were obtained after transform the recombinant plasmids into the competent saccharomyces cerevisiae. Then the whole yeast HPV16 - E7 vaccine was prepared by heat- inactivation. C57BL/6 mice were immunized with the vaccine, and the serum cytokines, the proliferation of spleen lymphocyte and the CTL function induced with the vaccine were detected by ELISA, MMT and LDH, respectively. Results HPV16 E7 gene could be efficiently expressed by the whole yeast vaccine. The vaccine could stimulate the proliferation of spleen lymphocyte, moreover, activate the Thl cytokines and the specific CTL function of mice. The immune effect of the whole yeast vaccine was more efficient than that of HPV16 - E7 protein (P〈0. 01). Conclusions The whole yeast vaccine could express HPV16 -E7 protein, and induce the specific CTL immune response efficiently. Further exploration of anti- tumor effect of the yeast vaccine can be based on these results.
出处 《中国妇产科临床杂志》 2009年第2期123-126,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 福建省自然科学基金(Z0516063)资助
关键词 人乳头状瘤病毒 E7基因 酿酒酵母 疫苗 免疫原性 uman papillomovirus HPV16 E7 gene saccharomyces cerevisiae vaccine immunogenicity
  • 相关文献

参考文献10

  • 1Wansley EK,Chakraborty M,Hance KW,et al.Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.Clin Cancer Res,2008,14:4316-4325.
  • 2Haller AA,Lauer GM,King THH,et al.Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.Vaccine,2007,25:1452-1463.
  • 3Sambrook J,Russell D.分子克隆实验指南.3版,北京:科学出版社,2002:87
  • 4Krieg AM.CpG motifs in bacterial DNA and their immune effect.Annu Rev Immunol,2002,20:709-760.
  • 5Andreakos E,Williams RO,Wales J,et al.Activation of NF-KB by the intracellular expression of NF-KB-inducing kinase acts as a powerful vaccine adjuvant.PNAS,2006,103:14459-14464.
  • 6Sheng KC,Pouniotis DS,Wright MD,et al.Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.Immunology,2006,118:372-383.
  • 7Lu Y,Bellgrau D,Dwyer-Nield LD,et al.Mutation-selective tumor remission with Ras-targeted,whole yeast-based immunotherapy.Cancer Res,2004,64:5084-5088.
  • 8Riemann H,Takao J,Shellman YG,et al.Generation of a prophylactic melanoma vaccine using whole recombinant yeast expressing MART-1.Exp Dermatol,2007,16:814-822.
  • 9张少恩,熊茜,唐海兵,刘俊云,吴园园,吴道贫,田文志,陆家海,郑伯建,孙娟.基因工程杂交酵母艾滋病疫苗研究[J].中华微生物学和免疫学杂志,2006,26(11):1033-1037. 被引量:3
  • 10Zur Hausen H.Papillomaviruses and cancer:from basic studies to clinical application.Nat Rev Cancer,2002,2:342-350.

二级参考文献11

  • 1Migueles SA,Laborico AC,Shupert WL,et al.HIV-specific CD8^+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.Nat Immunol,2002,3(11):1061-1068.
  • 2Lichterfeld M,Kaufmann DE,Yu XG,et al.Loss of HIV-1-specific CD8^+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4^+ T cells.J Exp Med,2004,200(6):701-712.
  • 3Amo A,Ruiz L,Juan M,et al.Efficacy of low-dose subcutanecus interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with ≥250/μl CDT cells and undetectable plasma virus load.J Infect Dis,1999,180(1):56-60.
  • 4Davey RT Jr,Chaitt DG,Piscitelli SC,et al.Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.J Infect Dis,1997,175(4):781-789.
  • 5Nacsa J,Edghill-Smith Y,Tsai WP,et al.Contrasting effects of lowdose IL-2 on vaccine-boosted simian immunodeficiency virus (SIV)-specific CD4^+ and CD8^+ T cells in macaques chronically infected with SIV-mac251.J Immunol,2005,174(4):1913-1921.
  • 6Williams DL,Pretus HA,McNamee RB,et al.Development of a watersoluble,sulfated(1-> 3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae.Carbohydr Res,1992,235:247-257.
  • 7Rios-Hernandez M,Dos-Santos NJ,Silvia-Cardoso,et al.Immunopharmacological studies of β-1,3-glucan.Arch Med Res,1994,25(2):179-180.
  • 8Stubbs AC,Martin KS,Coeshott C,et al.Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.Nat Med,2001,7(5):625-629.
  • 9Robinson HL.New hope for an AIDS vaccine.Nat Rev Immunol,2002,2(4):239-250.
  • 10Offringa R,van der Burg SH,Ossendorp F,et al.Design and evaluation of antigen-specific vaccination strategies against cancer.Curr Opin Immunol,2000,12(5):576-582.

共引文献3

同被引文献30

  • 1黄庆,府伟灵,周玉,张雪,黄君富,陈斌.基因芯片对人乳头瘤病毒的快速检测和分型[J].中华医院感染学杂志,2005,15(4):476-478. 被引量:50
  • 2陶萍萍,卞美璐,李敏,刘军.HPV多重感染与宫颈病变关系探讨[J].中国妇产科临床杂志,2006,7(2):94-96. 被引量:112
  • 3黄进波,叶珊.基因芯片检测人乳头瘤病毒23种亚型的应用评价[J].中国皮肤性病学杂志,2007,21(2):78-81. 被引量:10
  • 4Iftner T, Eberle S, Iftner A, et al. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age:an epidemiological observational study[J]. J Med Virol,2010,82(11) :1928-1939.
  • 5Torres LA, Rojo HG, Torres RA, et al. Cervical cancer: current view of its epidemiology and risk factors[J]. Gineeol Obstet Mex, 2004,72 :466-474.
  • 6Ho GY,Bierman R,Beardsley L,et al. Natural history of cervico vaginal papillomavirus infection in yong women[J]. N Eng J Med, 1998,338(7) :423-428.
  • 7Chang DY,Chen RJ,Lee SC,et al. Prevalence of single and muhi- ple infection with human papillomaviruses in various grades of cervical neoplasia[J]. J Med Microbiol, 1997,46( 1 ) : 54-60.
  • 8Iftner T, Eberle S, Iftner A, et al.Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age:an epidemiological observational study[J].J Med Virol, 2010,82 ( 11 ): 1928-1939.
  • 9Walboomers JM, Jacobs MV;et al.Human papillomavirus is necessary cause of invasive cervical cancer worldwide[J].J Pathol, 1999,189 : 12-19.
  • 10Torres LA, Rojo HG, Tortes RA, et al.Cervical cancer:current view of its epidemiology and risk factors[J].Ginecol Obstet Mex, 2004,72:466- 474.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部